IBRX vs. NVDA
Compare and contrast key facts about ImmunityBio, Inc. (IBRX) and NVIDIA Corporation (NVDA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IBRX or NVDA.
Key characteristics
| IBRX | NVDA | |
|---|---|---|
| YTD Return | 5.58% | 200.70% |
| 1Y Return | 54.52% | 219.76% |
| 3Y Return (Ann) | -14.67% | 69.41% |
| 5Y Return (Ann) | 36.56% | 96.14% |
| Sharpe Ratio | 0.41 | 4.33 |
| Sortino Ratio | 1.46 | 4.15 |
| Omega Ratio | 1.18 | 1.54 |
| Calmar Ratio | 0.49 | 8.28 |
| Martin Ratio | 1.32 | 26.13 |
| Ulcer Index | 34.83% | 8.58% |
| Daily Std Dev | 112.98% | 51.72% |
| Max Drawdown | -97.14% | -89.73% |
| Current Drawdown | -87.46% | 0.00% |
Fundamentals
| IBRX | NVDA | |
|---|---|---|
| Market Cap | $3.62B | $3.57T |
| EPS | -$0.96 | $2.21 |
| Total Revenue (TTM) | $1.23M | $78.19B |
| Gross Profit (TTM) | -$12.30M | $59.77B |
| EBITDA (TTM) | -$269.91M | $52.02B |
Correlation
The correlation between IBRX and NVDA is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
IBRX vs. NVDA - Performance Comparison
In the year-to-date period, IBRX achieves a 5.58% return, which is significantly lower than NVDA's 200.70% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
IBRX vs. NVDA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ImmunityBio, Inc. (IBRX) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
IBRX vs. NVDA - Dividend Comparison
IBRX has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBRX ImmunityBio, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.02% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% | 1.70% | 1.94% |
Drawdowns
IBRX vs. NVDA - Drawdown Comparison
The maximum IBRX drawdown since its inception was -97.14%, which is greater than NVDA's maximum drawdown of -89.73%. Use the drawdown chart below to compare losses from any high point for IBRX and NVDA. For additional features, visit the drawdowns tool.
Volatility
IBRX vs. NVDA - Volatility Comparison
ImmunityBio, Inc. (IBRX) has a higher volatility of 39.19% compared to NVIDIA Corporation (NVDA) at 11.24%. This indicates that IBRX's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
IBRX vs. NVDA - Financials Comparison
This section allows you to compare key financial metrics between ImmunityBio, Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities